Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion type Assertion NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_head.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion description "[Exon 20 PIK3CA mutations are relatively frequent in Her-2+ breast tumors and shorten survival, whereas neither exons 9 and 20 mutations seem related with " triple negative " breast carcinomas ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_provenance.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion evidence source_evidence_literature NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_provenance.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion SIO_000772 18679714 NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_provenance.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion wasDerivedFrom lhgdn-20090331 NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_provenance.
- NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_assertion wasGeneratedBy ECO_0000203 NP100084.RAt-57t5d5sFoOmI73EyBNTdo2oFg5U4SGoyN8qvpIB2Q130_provenance.